Related Experiment Video

Updated: Aug 23, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.1K

Compartmentalized activities of HMGCS1 control cervical cancer radiosensitivity

Xiaomin Zhang1, Congcong Sun1, Jinliang Wan2

  • 1Department of Obstetrics and Gynecology, Binzhou Medical University Hospital, Binzhou, Shandong 256603, PR China.

Cellular Signalling
|November 3, 2022
PubMed

Insights

Loss of 3-hydroxy-3-methylglutaryl coenzyme A synthase 1 (HMGCS1) sensitizes cervical cancer cells to radiation. This enzyme impacts cholesterol metabolism and mitochondrial function, suggesting HMGCS1 as a therapeutic target for cervical cancer radiotherapy.

Area of Science:

  • Biochemistry
  • Oncology
  • Cellular Metabolism

Background:

  • Cellular metabolism's role in cervical cancer radiosensitivity is not well understood.
  • Identifying key metabolic regulators is crucial for improving radiotherapy outcomes.

Purpose of the Study:

  • To investigate the role of 3-hydroxy-3-methylglutaryl coenzyme A synthase 1 (HMGCS1) in cervical cancer cell radiosensitivity.
  • To elucidate the mechanisms by which HMGCS1 influences radiosensitivity.

Main Methods:

  • Analysis of HMGCS1 expression and localization in cervical cancer cells.
  • Investigating the impact of HMGCS1 on cholesterol metabolism and mitochondrial function.
  • Assessing the effect of HMGCS1 modulation on radiosensitivity.

Main Results:

  • Loss of HMGCS1 sensitizes cervical cancer cells to radiation.
  • HMGCS1 is compartmentalized in the nucleus, cytosol, and mitochondria.
  • Cytosolic HMGCS1 affects cholesterol metabolism, while mitochondrial HMGCS1 influences mitochondrial gene expression and function.

Conclusions:

  • HMGCS1 is a novel regulator of radiosensitivity in cervical cancer.
  • HMGCS1 links cholesterol metabolism, mitochondrial respiration, and radiosensitivity.
  • Targeting HMGCS1 may enhance the efficacy of cervical cancer radiotherapy.
Keywords:
Cervical cancerMitochondrial DNA expressionMitochondrial functionRadiosensitivity

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.6K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

8.8K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Cell Cycle Control System01:28

The Cell Cycle Control System

The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
3.1K